For the second installment in our ABclonal Webinar Series, we had the privilege of inviting Dr. Clarke Gasper, our Business Development Scientist, to share his insights on the production and development of monoclonal antibodies for cancer therapy. If you were unable to attend the live session or would like to re-watch to review some of Dr. Gasper’s key points, we’ve got you covered with a link to a recording of the webinar and Q&A here, as well as a recap of his lecture below.
ABclonal is a China-based biotechnology company that researches and develops antibodies and molecular enzyme products for industries such as life science and pharmaceuticals.